Rentschler Biopharma sets foot in the U.S. to strengthen its world-class CDMO position

March 13, 2019 Rentschler Biopharma sets foot in the U.S. to strengthen its world-class CDMO position

An article written by our SVP Business Development Federico Pollano for the Q1 issue of pharma’s almanac

With our new production site, we are able to answer our U.S. clients’ strong request to bring our innovation and technology to their doorstep, underscoring our deep commitment to meeting their unique market needs. Click here for the full article.

Contact Person:
Rentschler Biopharma SE
Dr. Cora Kaiser
Senior Director Corporate Communication
communications@rentschler-biopharma.com